Can Probiotics Help In Preventing Or Slowing Down Male Pattern Baldness?
Quick answer
Current evidence does not support probiotics as effective in preventing male pattern baldness (androgenetic alopecia), though some early studies suggest potential benefits that require further research.
🔬 What the research shows
A high-evidence randomized controlled trial (PMID: 39275216) tested a probiotic mixture on individuals with androgenetic alopecia, including men, and found a significant reduction in telogen hairs and prevention of hair thickness decrease compared to placebo. However, the strains used were not specified, limiting strain-specific conclusions. Another low-evidence research study (PMID: 41706407) discussed the theoretical role of Lactobacillus strains in modulating gut microbiota to influence alopecia through immunoregulatory and antioxidant effects, but emphasized the need for more randomized controlled trials. No other studies directly addressed probiotics for male pattern baldness. Overall, evidence is preliminary and strain-specific effects remain unclear.
Best studied probiotic strains
Unspecified probiotic mixture
High-quality randomized controlled trial (PMID: 39275216) showed reduction in telogen hairs and prevention of hair thickness loss in androgenetic alopecia patients, including men.
Strains were not specified in the study, limiting ability to recommend specific probiotic strains for male pattern baldness.
Lactobacillus (general)
Low-evidence research (PMID: 41706407) suggests Lactobacillus strains may have immunoregulatory and antioxidant properties that could influence alopecia via the gut-hair axis.
Evidence is theoretical and requires further randomized controlled trials to confirm efficacy and strain specificity.
👥 Who may benefit
✅ Safety
Probiotic supplementation was well tolerated in the clinical trial with a high adherence rate and no reported adverse effects related to probiotic intake.
⚠️ Limitations
Limited number of studies directly addressing probiotics for male pattern baldness; lack of strain specification in key clinical trial; low evidence from mechanistic studies; need for larger, longer-term randomized controlled trials to confirm findings and identify effective strains.